Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

PHARMION CORPORATION

PHARMION CORPORATION is a federal contractor, registered under UEI HSHKJU1HUJN5. It has been awarded $158,018 in federal contracts. Primary work spans Pharmaceutical Preparation Manufacturing. Top awarding agencies include Department Of Veterans Affairs.

Contact Information

Registration and classification details

Registration

UEI Code

HSHKJU1HUJN5

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Pharmion Corporation specializes in pharmaceutical preparation manufacturing, with a specific technical focus on the provision of injectable contrast media, such as Ultravist Injection. Their core capabilities center on the supply and distribution of specialized pharmaceutical preparations required ...

Pharmion Corporation specializes in pharmaceutical preparation manufacturing, with a specific technical focus on the provision of injectable contrast media, such as Ultravist Injection. Their core capabilities center on the supply and distribution of specialized pharmaceutical preparations required for medical imaging and diagnostic procedures. The company maintains a dedicated relationship with the Department of Veterans Affairs, where they serve as a supplier of critical pharmaceutical products to support veteran healthcare services. Their industry focus is concentrated within NAICS 325412, positioning them as a specialized provider within the pharmaceutical manufacturing sector. They operate primarily as a vendor of medical-grade injectable solutions for government healthcare facilities.

Key performance metrics

Award counts and award dollars by type, as prime and as subcontractor.

Awards Count

37

All time

Active

0

Currently performing

Completed

37

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award analytics

Awards by agency, industry, year, award type, size, and place of performance.

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with PHARMION CORPORATION

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for PHARMION CORPORATION

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in PHARMION CORPORATION's top NAICS codes and agencies

NAICS: 325412
New
Federal
6505--Request for Information (RFI) - Specialty – PPV 2028 Amendment 0002 to Extend Response Date from Nov. 16, 2026 to Nov. 30, 2026 at 11AM CT
Solicitation # 36E79727Q0001
The Department of Veterans Affairs, through the OALC Enterprise Procurement Office, has issued a Request for Information regarding the Pharmaceutical Prime Vendor (PPV) 2028 program. The agency is seeking market research to determine the feasibility of integrating Limited Distribution and Closed Distribution Products (CDP) into the PPV scope. These specialty medications are typically high-cost, low-volume items with restricted distribution channels that often require specific clinical justifications, manufacturer-mandated registrations, and specialized safety monitoring. The primary objective is to establish a seamless ordering platform where all Federal Supply Schedule (FSS) items, including those that bypass the physical possession of the prime vendor, are visible and orderable with accurate invoicing and delivery tracking for VA medical centers nationwide. The government is soliciting detailed feedback from industry partners on their ability to coordinate fulfillment with manufacturer-designated specialty distributors and their capacity to provide consistent reporting and reconciliation for these transactions. Potential respondents must provide their company name, point of contact information, UEI, CAGE code, and any applicable socioeconomic designations. Submissions are due by 11 AM Central on November 16, 2026, via email to Karen Ade. This notice is strictly for market research purposes and does not constitute a formal solicitation or a commitment by the government to award a contract.
Nac Prime Vendor (36W797)

POSTED

about 15 hours ago

DEADLINE

in 21 days
View Details